SCHEMBL381228

SCHEMBL381228

CC(C)(C)N(C(=O)O)C(CCO)c1cccc(Cl)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
NFKB1 P19838 1/20 0.36
PNMT P11086 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
CACNA2D1 P54289 4/20 0.35
CACNA1B Q00975 4/20 0.35
CACNB1 Q02641 4/20 0.35
CACNA1C Q13936 1/20 0.35
TSHR P16473 1/20 0.34
CXCL8 P10145 1/20 0.34
CNR1 P21554 1/20 0.33
MAPK1 P28482 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19244855 0.89 MEN1 (0.41) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL16504458 0.87 CFD (0.41) CXCL8OPRM1
SCHEMBL16504457 0.87 CFD (0.41) CXCL8OPRM1
SCHEMBL381393 0.85 NISCH (0.43) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL16674049 0.81 MEN1 (0.37) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL19244879 0.81 MEN1 (0.37) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL19244878 0.80 OPRM1 (0.39) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL380995 0.79 KMT2A (0.36) MEN1KMT2ACYP2D6NFKB1CXCL8
SCHEMBL381469 0.78 GAA (0.38) MEN1KMT2ACYP3A4ALDH1A1OPRM1
SCHEMBL16504760 0.78 MEN1 (0.41) MEN1KMT2AALDH1A1CACNA2D1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-B1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof BAYER IP GMBH (DE) 2017-08-23 EP disclosed
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed